hemangiol
pierre fabre medicament - propranolol - hemangiom - agenți beta blocanți - hemangiol is indicated in the treatment of proliferating infantile haemangioma requiring systemic therapy: , life- or function-threatening haemangioma,, ulcerated haemangioma with pain and/or lack of response to simple wound care measures,, haemangioma with a risk of permanent scars or disfigurement. , it is to be initiated in infants aged 5 weeks to 5 months.
anaprilin-zdorovie 10 mg comprimate
compania farmaceutică "zdorovie" srl - propranololum - comprimate - 10 mg
anaprilin comprimate 40 mg
upm din borisov sad - propranololum - comprimate - 40 mg
hemangiol 3,75 mg/ml
farmea - franta - propranololum - sol. orala - 3,75 mg/ml - agenti betablocanti betablocante neselective
uteroton, soluție injectabilă
ooo nita-farm, rusia - propranolol - soluţie injectabilă
finoptin comprimate filmate 40 mg
orion corporation - verapamilum - comprimate filmate - 40 mg
finoptin comprimate filmate 80 mg
orion corporation - verapamilum - comprimate filmate - 80 mg
diltiazem retard capsule cu eliberare prelungita 180 mg
rompharm company srl, sc - diltiazemum - capsule cu eliberare prelungita - 180 mg
diltiazem retard capsule cu eliberare prelungita 90 mg
rompharm company srl, sc - diltiazemum - capsule cu eliberare prelungita - 90 mg
topamax capsule 25 mg
johnson & johnson srl - topiramatum - capsule - 25 mg